These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9151831)

  • 21. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.
    Ott DE; Chertova EN; Busch LK; Coren LV; Gagliardi TD; Johnson DG
    J Virol; 1999 Jan; 73(1):19-28. PubMed ID: 9847302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
    Mammano F; Kondo E; Sodroski J; Bukovsky A; Göttlinger HG
    J Virol; 1995 Jun; 69(6):3824-30. PubMed ID: 7745730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.
    González SA; Affranchino JL
    Virology; 1998 Jan; 240(1):27-35. PubMed ID: 9448686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
    Ono A; Freed EO
    J Virol; 1999 May; 73(5):4136-44. PubMed ID: 10196310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions.
    Yu X; Yuan X; McLane MF; Lee TH; Essex M
    J Virol; 1993 Jan; 67(1):213-21. PubMed ID: 8416370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient HIV-1 replication can occur in the absence of the viral matrix protein.
    Reil H; Bukovsky AA; Gelderblom HR; Göttlinger HG
    EMBO J; 1998 May; 17(9):2699-708. PubMed ID: 9564051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation.
    Kalia V; Sarkar S; Gupta P; Montelaro RC
    J Virol; 2003 Mar; 77(6):3634-46. PubMed ID: 12610139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
    Joshi A; Nagashima K; Freed EO
    J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle.
    Van Duyne R; Kuo LS; Pham P; Fujii K; Freed EO
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9040-9049. PubMed ID: 30975760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation.
    Eastep GN; Ghanam RH; Green TJ; Saad JS
    J Biol Chem; 2021; 296():100321. PubMed ID: 33485964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.
    Fouchier RA; Simon JH; Jaffe AB; Malim MH
    J Virol; 1996 Dec; 70(12):8263-9. PubMed ID: 8970945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein.
    Huang M; Martin MA
    J Virol; 1997 Jun; 71(6):4472-8. PubMed ID: 9151838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A bipartite membrane-binding signal in the human immunodeficiency virus type 1 matrix protein is required for the proteolytic processing of Gag precursors in a cell type-dependent manner.
    Lee YM; Tian CJ; Yu XF
    J Virol; 1998 Nov; 72(11):9061-8. PubMed ID: 9765451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
    Lee PP; Linial ML
    J Virol; 1994 Oct; 68(10):6644-54. PubMed ID: 7521919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
    Berthoux L; Péchoux C; Ottmann M; Morel G; Darlix JL
    J Virol; 1997 Sep; 71(9):6973-81. PubMed ID: 9261426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
    Accola MA; Höglund S; Göttlinger HG
    J Virol; 1998 Mar; 72(3):2072-8. PubMed ID: 9499062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation.
    Tedbury PR; Novikova M; Ablan SD; Freed EO
    Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E182-90. PubMed ID: 26711999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport.
    Soneoka Y; Kingsman SM; Kingsman AJ
    J Virol; 1997 Jul; 71(7):5549-59. PubMed ID: 9188629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA.
    Bukrinskaya AG; Ghorpade A; Heinzinger NK; Smithgall TE; Lewis RE; Stevenson M
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):367-71. PubMed ID: 8552640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.